Research advances on CD47 in digestive system cancers: from molecular mechanisms to clinical translation
Haolin Sun, Chenyu Wei, Jianglan Long, Xiaojia Liu, Quanfu Li, Bangwei Cao · 2026
Read Research advances on CD47 in digestive system cancers: from molecular mechanisms to clinical translation by Haolin Sun, Chenyu Wei, Jianglan Long, Xiaojia Liu, Quanfu Li, Bangwei Cao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13625503.txt.
Description
Haolin Sun and colleagues review CD47 in cancers of the digestive system in a 2026 paper. CD47 is a checkpoint molecule on cell surfaces. It tells macrophages not to eat the cell that bears it. Tumors can exploit that signal to escape immune attack. Faulty CD47 levels link to resistance and poor patient features.
The review covers CD47 structure, partners, and signaling roles. Expression patterns are summed up across six digestive cancer types. Those span the esophagus, stomach, bowel, liver, pancreas, and bile ducts. Treatments targeting the CD47 pathway are then reviewed in depth. Options include antibodies, fusion proteins, and bispecific designs. Cell-based and nano-based platforms appear as newer routes. Strength of evidence varies by tumor type.
Catalog record
| CREATOR | Haolin Sun, Chenyu Wei, Jianglan Long, Xiaojia Liu, Quanfu Li, Bangwei Cao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |